Curated from 2,322 episode summaries
Drug policy is one of those topics where everybody has an opinion and almost nobody has sat with a scientist, a policy insider, or a chemist who has actually done the fieldwork. We went through our full library of podcast summaries and pulled the episodes that get past the talking points, the ones where a guest brings receipts: overdose data, brain-imaging results, sentencing statistics, or a personal account of what a drug actually does to a body.
This isn't a debate-club list stacked with people who agree with each other. It runs from a Columbia neuroscientist arguing for full legalization to the director of the National Institute on Drug Abuse defending the research establishment, with detours into psychedelic science and the geopolitics of the fentanyl trade. Pick the angle you're least familiar with and start there.
Carl Hart: Heroin, Cocaine, MDMA, Alcohol & the Role of Drugs in Society | Lex Fridman Podcast #233
Carl Hart chairs the psychology department at Columbia and openly uses heroin and cocaine in his private life, which he brings up in the first two minutes to get it out of the way. His argument to Lex Fridman is blunt: the predominant effects of heroin, cocaine, MDMA, and psilocybin are positive, the main health complaint from regular heroin use is constipation rather than the catastrophe pop culture describes, and addiction tracks with poverty and psychosocial stress far more than with any drug's chemistry. He wants everything legally regulated and available to adults. Listen if you want the fullest, least hedged case for legalization from someone whose job depends on knowing the pharmacology cold.
Read the full episode notesThinking Differently About Addiction and Mental Health — Dr. Nora Volkow
As director of NIDA, Volkow has spent decades imaging the brains of drug users, and she brings a very different vantage point than Hart's. She traces 2016 as the moment fentanyl's cheap synthesis made it 'transformative' and malignant, explains that dealers now cut it with xylazine, a veterinary sedative Narcan can't touch, and states flatly that the War on Drugs 'created a mechanism that could perpetuate structural racism' by way of crack-versus-powder cocaine sentencing. She also lays out real experimental data on curing addiction, including a single ten-minute ultrasound session that cut cravings for weeks. This is the episode for anyone who wants the public-health establishment's best version of the argument, not a strawman of it.
Read the full episode notesMatthew Johnson: Psychedelics | Lex Fridman Podcast #145
Johnson runs psychedelic research at Johns Hopkins and applies a behavioral-economics lens to addiction, using demand curves and delay discounting to explain why heavily taxing cigarettes can actually make life worse for smokers who are already fully hooked. He puts hard numbers on the drug-policy conversation too: nicotine kills roughly four times more Americans than alcohol, and his psilocybin-for-smoking-cessation trial produced 59 percent abstinence at one year against 27 percent for the nicotine patch. Good listen for anyone who wants the addiction-science argument for reform without the culture-war framing.
Read the full episode notesHamilton Morris on Iboga, 5-MeO-DMT, the Power of Ritual, New Frontiers in Psychedelics, and More
Morris, the chemist and documentarian behind Hamilton's Pharmacopeia, takes the conversation somewhere most drug-policy talk never goes: sustainability. He argues that surging demand for iboga, peyote, and toad venom is stripping ecosystems bare, and that lab synthesis is often the more ethical choice than harvesting wild plants and animals. He also dismantles a popular myth, showing there's essentially no evidence of historical indigenous use of the Sonoran Desert toad the modern psychedelic scene reveres. Worth it for anyone tired of legalization debates that never touch what happens to the plants and animals once demand goes mainstream.
Read the full episode notesJoe Rogan Experience #2211 - Michael Shellenberger
Shellenberger and Rogan spend a long middle stretch on prohibition, addiction, and the fentanyl trade, with Rogan citing roughly 112,000 US overdose deaths in a single year, up from about 20,000 in 2000, with fentanyl involved in around three-quarters of them. Shellenberger counters with the case that Vietnam veterans who came home addicted to heroin mostly quit without treatment, and that addicted doctors have very low relapse rates, both used to argue environment matters more than the drug itself. It's a messier, more adversarial conversation than the others on this list, useful for hearing the debate as it actually plays out between two non-specialists working through the data live.
Read the full episode notesThat's five episodes that treat drug policy as something worth actually studying rather than shouting about. Browse the rest of our episode summaries for more conversations that go deep instead of loud.